<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Verginelli F</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><funding>Ministero dell’Istruzione, dell’Università e della Ricerca</funding><funding>NCI NIH HHS</funding><pagination>779-798</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5904229</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>135(5)</volume><pubmed_abstract>Tumours can be viewed as aberrant tissues or organs sustained by tumorigenic stem-like cells that engage into dysregulated histo/organogenetic processes. Paragangliomas, prototypical organoid tumours constituted by dysmorphic variants of the vascular and neural tissues found in normal paraganglia, provide a model to test this hypothesis. To understand the origin of paragangliomas, we built a biobank comprising 77 cases, 18 primary cultures, 4 derived cell lines, 80 patient-derived xenografts and 11 cell-derived xenografts. We comparatively investigated these unique complementary materials using morphofunctional, ultrastructural and flow cytometric assays accompanied by microRNA studies. We found that paragangliomas contain stem-like cells with hybrid mesenchymal/vasculoneural phenotype, st</pubmed_abstract><journal>Acta neuropathologica</journal><pubmed_title>Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.</pubmed_title><pmcid>PMC5904229</pmcid><funding_grant_id>2015B7M39T</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>IG9168</funding_grant_id><funding_grant_id>IG16932</funding_grant_id><pubmed_authors>Guarnieri S</pubmed_authors><pubmed_authors>Marchisio M</pubmed_authors><pubmed_authors>Opocher G</pubmed_authors><pubmed_authors>Veronese A</pubmed_authors><pubmed_authors>Soderberg-Naucler C</pubmed_authors><pubmed_authors>Sanna M</pubmed_authors><pubmed_authors>Sheu A</pubmed_authors><pubmed_authors>Rajasekhar VK</pubmed_authors><pubmed_authors>Tramontana L</pubmed_authors><pubmed_authors>Vespa S</pubmed_authors><pubmed_authors>Rossi C</pubmed_authors><pubmed_authors>Verginelli F</pubmed_authors><pubmed_authors>Bologna G</pubmed_authors><pubmed_authors>Paties CT</pubmed_authors><pubmed_authors>Morgano A</pubmed_authors><pubmed_authors>Cama A</pubmed_authors><pubmed_authors>Schiavi F</pubmed_authors><pubmed_authors>Esposito DL</pubmed_authors><pubmed_authors>Lanuti P</pubmed_authors><pubmed_authors>D'Argenio A</pubmed_authors><pubmed_authors>Pantalone MR</pubmed_authors><pubmed_authors>Florio R</pubmed_authors><pubmed_authors>Lotti LV</pubmed_authors><pubmed_authors>Taschin E</pubmed_authors><pubmed_authors>Visone R</pubmed_authors><pubmed_authors>Mariani-Costantini R</pubmed_authors><pubmed_authors>Perconti S</pubmed_authors><pubmed_authors>Prasad SC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.</name><description>Tumours can be viewed as aberrant tissues or organs sustained by tumorigenic stem-like cells that engage into dysregulated histo/organogenetic processes. Paragangliomas, prototypical organoid tumours constituted by dysmorphic variants of the vascular and neural tissues found in normal paraganglia, provide a model to test this hypothesis. To understand the origin of paragangliomas, we built a biobank comprising 77 cases, 18 primary cultures, 4 derived cell lines, 80 patient-derived xenografts and 11 cell-derived xenografts. We comparatively investigated these unique complementary materials using morphofunctional, ultrastructural and flow cytometric assays accompanied by microRNA studies. We found that paragangliomas contain stem-like cells with hybrid mesenchymal/vasculoneural phenotype, st</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 May</publication><modification>2025-04-04T10:09:57.214Z</modification><creation>2019-03-26T23:31:41Z</creation></dates><accession>S-EPMC5904229</accession><cross_references><pubmed>29305721</pubmed><doi>10.1007/s00401-017-1799-2</doi></cross_references></HashMap>